Florida Pharmaceutical Products, LLCUsage: Exemestane is indicated for postmenopausal women with estrogen-receptor positive early breast cancer as adjuvant treatment after 2-3 years of tamoxifen, and for advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.